There are 511 resources available
442P - AI routine blood signature as a tumour marker to predict post-treatment outcomes in gastric cancer
Presenter: Ka Man Cheung
Session: Poster Display session
Resources:
Abstract
443P - TRIfluridine vs FOLfiri in thIrd-Line Metastatic gastroesophageal adenocarcinoma (mGEA): The TRIFOLIUM study
Presenter: Eleonora Perissinotto
Session: Poster Display session
Resources:
Abstract
444P - Clinicopathological characteristics and prognosis of HER2-low advanced/metastatic gastric cancer
Presenter: Wendy Chan
Session: Poster Display session
Resources:
Abstract
445P - Survival among patients cured from gastric adenocarcinoma compared to the background population
Presenter: Wilhelm Leijonmarck
Session: Poster Display session
Resources:
Abstract
446P - A prospective study for real-world data (RWD) of ramucirumab plus paclitaxel in patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (KCSG ST21-06)
Presenter: Dae Young Zang
Session: Poster Display session
Resources:
Abstract
447P - Artificial intelligence-assisted sponge cytology for screening of esophageal squamous cell carcinoma and adenocarcinoma of the esophagogastric junction in China: A multicenter case-control study
Presenter: Minjuan Li
Session: Poster Display session
Resources:
Abstract
448P - Disitamab vedotin (RC48) combined with programmed death-1 inhibitor for pre-treated HER2 expressed (IHC 2+/3+) advanced gastric cancer: A multi-center real-world study
Presenter: Xiao Yan
Session: Poster Display session
Resources:
Abstract
449P - The safety and efficacy of neoadjuvant immunochemotherapy followed by laparoscopic gastrectomy for gastric cancer: A multicenter real-world clinical study
Presenter: Yu-Qin Sun
Session: Poster Display session
Resources:
Abstract
450P - Neoadjuvant chemo-immunotherapy in mismatch repair deficient (dMMR)/microsatellite instability (MSI) gastric carcinoma (GC): A multicenter retrospective study
Presenter: Henian Sun
Session: Poster Display session
Resources:
Abstract
451P - Assessment of PD-L1 on matched surgical specimen and biopsy in resectable esophagogastric cancer (EGC): The APEROL study
Presenter: Floriana Nappo
Session: Poster Display session
Resources:
Abstract